• C Le Hello, L Fouillet, C Boulon, S Rivière, A El Jaouhari, B Seffert, A Morel, and C Boissier.
• Département de Médecine Vasculaire et Thérapeutique, Centre Hospitalier Universitaire, Saint-Étienne, France; Campus Santé et Innovations, Université Jean Monnet, St-Priest-en-Jarez, France; INSERM, U1059 Sainbiose, Université de Lyon, Saint-Étienne, France. Electronic address: claire.lehello@chu-st-etienne.fr.
• Rev Med Interne. 2020 Oct 1; 41 (10): 667672667-672.

AbstractPeripheral arterial disease is a result of atheroma. This disease is frequent in subjects with vascular risk factors. This disease is also frequent in low income countries. The detection and the diagnosis of peripheral arterial disease is obtained by calculating the ankle brachial index. Patients with peripheral arterial disease are not always symptomatic thus explaining how this disease is under diagnosed. The symptoms can be absent, and especially in case of diabetes or in women. In case of peripheral arterial disease, atheroma often involves other arterial vascular networks especially the coronaries. An adapted treatment reduces the morbi-mortality linked to this disease. This treatment is based on the correction of the vascular risk factors and especially tobacco cessation, walking rehabilitation and drugs (antiplatelet agent, statin, renin angiotensin system blocker). In case of rest or critic ischemia, the first-line treatment is a revascularisation. In peripheral arterial disease, management of patients is often non optimal and therapeutic targets fairly often obtained.Copyright © 2020. Published by Elsevier Masson SAS.

26 keywords...

hide…